Search Results for: pericarditis

July 8, 2025

An Analysis of Studies Comparing Myocarditis and Pericarditis in COVID-19 Vaccinated and SARS-CoV-2 Infected Individuals.

Publication date: Jul 05, 2025 We sought to identify studies that examined myocarditis and pericarditis after both COVID-19 vaccination and SARS-CoV-2 infection. A literature search was conducted and retrospective cohort ... Read more

June 28, 2025

Severe Calcific Constrictive Pericarditis From Remotely Treated Tuberculosis.

Tuberculosis Literature

Publication date: Jun 25, 2025 Constrictive pericarditis from tuberculosis is a rare but serious consequence of a tuberculosis infection, especially in nonendemic areas. A 40-year-old man with a history of ... Read more

June 17, 2025

Difficult-to-treat recurrent pericarditis after SARS-CoV-2 vaccination.

Coronavirus Literature

Publication date: Jun 14, 2025 Pericarditis is a recognized but rare complication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination. While most cases are self-limited, some develop recurrent, difficult-to-treat ... Read more

June 6, 2025

Is It an Intrapericardial Mass or a Localized Pericardial Effusion? A Case Report of Tuberculous Pericarditis Evaluated by Multimodal Imaging.

Tuberculosis Literature

Publication date: Jun 04, 2025 Tuberculous pericarditis is often difficult to diagnose because of atypical symptoms and insufficient etiology examination. We present a case wherein the patient initially presented with ... Read more

$An Open-Label Phase 1/2A Study of GV20-0251 in Participants With Advanced and/or Refractory Solid Tumor Malignancies$

July 18, 2025

An Open-Label Phase 1/2A Study of GV20-0251 in Participants With Advanced and/or Refractory Solid Tumor Malignancies

Melanoma News

Publication date: Jul 16, 2025 This is a Phase 1 and Phase 2 study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory ... Read more

July 16, 2025

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.

Coronavirus Literature

Publication date: Jul 15, 2025 The safety of XBB. 1.5-containing COVID-19 mRNA vaccines warrants investigation. We assessed the relative risk of 15 adverse events following the XBB. 1.5 vaccination using ... Read more

July 12, 2025July 12, 2025

Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial.

Coronavirus Literature

Publication date: Jul 07, 2025 mRNA-1283 is an investigational, next-generation COVID-19 vaccine that encodes only the immunodominant regions of the SARS-CoV-2 spike protein-the receptor-binding domain (RBD) and the N-terminal domain ... Read more

July 4, 2025

FDA steps up assessment of myocarditis following mRNA COVID-19 jabs

Coronavirus News

Publication date: Jul 04, 2025 The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 vaccine, noting the risk ... Read more

July 3, 2025

Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database.

Melanoma Literature

Publication date: Jul 01, 2025 The combination of immune checkpoint inhibitors (ICIs), such as ipilimumab and nivolumab, has revolutionized cancer treatment, particularly for advanced melanoma and other solid tumors. However, ... Read more

July 3, 2025

Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept.

Coronavirus Literature

Publication date: Jul 02, 2025 Rilonacept, an interleukin-1 (IL-1) “trap,” is FDA-approved for recurrent pericarditis, but research on its adverse reactions is limited due to its recent introduction. This study ... Read more